This is a working overview of 垂体受体, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-10-15. Anything still debated is marked as such rather than presented as settled.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
tesamorelin 是一种人工合成的四十四肽，序列与内源性生长激素释放激素（GHRH）的 1-44 片段一致，区别在于 N 端加接了一个反式-3-己烯酰基。该修饰抑制二肽基肽酶 IV 的快速切割，从而延长分子在循环中的存留时间。作为肽类分子，它难以经胃肠道吸收，文献中讨论的均是注射途径。分类上通常把它归为 GHRH 类似物，以区别于生长激素本身。
作用位置在垂体前叶。tesamorelin 与 GHRH 受体结合后激活腺苷酸环化酶，升高细胞内 cAMP，再经蛋白激酶 A 通路促进生长激素的合成与释放。由于它作用于内源调控节点，生长激素仍以脉冲方式分泌，而不是被持续抬升到固定水平。生长激素随后在肝脏等组织诱导胰岛素样生长因子 1 产生，构成完整的生长激素轴响应。
研究背景集中在特定人群的体成分改变，尤其是与脂肪分布异常相关的内脏脂肪堆积。不同地区对它的监管状态与获批适应症并不一致，部分市场仅限特定诊断人群使用。在一般人群中的长期效应、与其他激素的相互作用以及停药后的维持情况仍属开放问题，现有数据不足以给出普遍结论。
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
==== Sources ==== Formaldehyde (HCHO) enters the atmosphere via primary emission and secondary formation. Primary sources of atmospheric HCHO include direct biogenic emissions from vegetation and biomass burning, and anthropogenic emissions from vehicles, industrial activities, and coal combustion. Most atmospheric HCHO is secondary, produced by radical-driven oxidation of methane (CH4) and non-methane volatile organic compounds (VOCs) rather than direct emissions. Secondary production from CH4 oxidation dominates in remote and marine environments. Oxidation of biogenic and anthropogenic VOCs is the main source of HCHO in continental regions. Vegetation emits large amounts of isoprene, which is a key natural precursor of tropospheric formaldehyde over land.
f. antarctica (Vain.) Hue (1915) is now Polycauliona antarctica f. ectaneoides (Nyl.) Boistel (1903) is now Xanthoria ectaneoides f. ectaniza Boistel (1903) is now Rusavskia ectaniza f. polycarpa (Hoffm.) Arnold (1881) is now Polycauliona polycarpa subsp. calcicola (Oxner) Clauzade & Cl.Roux (1985) is now Xanthoria calcicola subsp. phlogina (Ach.) Sandst. (1912) is now Scythioria phlogina var. aureola (Ach.) Th.Fr. (1860) is now Xanthoria aureola var. australis Zahlbr. (1917) is now Jackelixia australis var. contortuplicata (Ach.) H.Olivier (1894) is now Xanthaptychia contortuplicata var. incavata (Stirt.) Js. Murray (1960) is now Dufourea incavata var. lobulata (Flörke) Rabenh. (1870) is now Seawardiella lobulata var. mandschurica Zahlbr. (1931) is now Zeroviella mandschurica var. rutilans (Ach.) Maheu & A.Gillet (1924) is now Xanthoria rutilans
https://doi.org/10.1016/j.jmb.2007.11.082 Switching DNA-binding specificity by unnatural amino acid substitution. Maiti, A., & Roy, S.* (2005) Nucleic Acids Res, 33, 5896-903. https://doi.org/10.1093/nar/gki899 Asynchronous basepair openings in transcription initiation: regulation by enhancing the rate limiting step. Roy, S., Lim, HM., & Adhya, S. (2004) EMBO J, 23, 869-75. https://doi.org/10.1038/sj.emboj.7600098 Fluorescence quenching methods to study protein-nucleic acid interaction. Roy, S.* (2004) Methods Enzymol, 379, 175-87. https://doi.org/10.1016/S0076-6879(04)79010-2 2-Aminopurine as a probe for Basepair opening during Transcription Initiation. Roy, S.* (2003) Methods Enzymol, 370, 568-76. https://doi.org/10.1016/S0076-6879(03)70048-2 Glutamate counteracts the denaturing effect of urea through its effect on the denatured state. Mandal, AK., Samaddar, S., Banerjee, R., Lahiri, S., Bhattacharyya, A., & Roy, S.* (2003) J Biol Chem, 278, 36077-84. https://doi.org/10.1074/jbc.M211207200 Solvation Change and Ion release During Aminoacylation by Aminoacyl-tRNA synthetases. Bannerjee, R., Mandal, AK., Shah, R., Guha, S., Samaddar, S., Bhattacharyya, A., & Roy, S.* (2003) Nucleic Acids Res, 31, 6035-42. https://doi.org/10.1093/nar/gkg779 Aib-based peptide backbone as scaffolds for helical peptide mimics. Banerjee, R., Basu, G.,* Roy, S.,* & Chene, P. (2002) J Pept Res, 60, 88-94.https://doi.org/10.1034/j.1399-3011.2002.201005.x DnaK-sigma32 interaction is temperature dependent: Implication for the mechanism of heat-shock response.
Sources: en.wikipedia.org
Cytokinins are a class of plant hormones named for their control of cell division (especially cytokinesis). The natural cytokinin zeatin was discovered in corn, Zea mays, and is a derivative of the purine adenine. Zeatin is produced in roots and transported to shoots in the xylem where it promotes cell division, bud development, and the greening of chloroplasts. The gibberelins, such as gibberelic acid are diterpenes synthesised from acetyl CoA via the mevalonate pathway. They are involved in the promotion of germination and dormancy-breaking in seeds, in regulation of plant height by controlling stem elongation and the control of flowering. Abscisic acid (ABA) occurs in all land plants except liverworts, and is synthesised from carotenoids in the chloroplasts and other plastids. It inhibits cell division, promotes seed maturation, and dormancy, and promotes stomatal closure. It was so named because it was originally thought to control abscission. Ethylene is a gaseous hormone that is produced in all higher plant tissues from methionine. It is now known to be the hormone that stimulates or regulates fruit ripening and abscission, and it, or the synthetic growth regulator ethephon which is rapidly metabolised to produce ethylene, are used on industrial scale to promote ripening of cotton, pineapples and other climacteric crops.
=== Methodology === Most tests employ a monoclonal antibody, which is specific to the β-subunit of hCG (β-hCG). This procedure is employed to ensure that tests do not make false positives by confusing hCG with LH and FSH. (The latter two are always present at varying levels in the body, whereas the presence of hCG almost always indicates pregnancy.) Many hCG immunoassays are based on the sandwich principle, which uses antibodies to hCG labeled with an enzyme or a conventional or luminescent dye. Pregnancy urine dipstick tests are based on the lateral flow technique.
Consensus scoring Selecting candidates by voting of multiple scoring functions May lose the relationship between protein-ligand structural information and scoring criterion Cluster analysis Represent and cluster candidates according to protein-ligand 3D information Needs meaningful representation of protein-ligand interactions.
Sources: en.wikipedia.org
=== Other animals with wrinkles === Examples of wrinkles can be found in various animal species that grow loose, excess skin, particularly when they are young. Several breeds of dog, such as the Pug and the Shar Pei, have been bred to exaggerate this trait. In dogs bred for fighting, this is the result of selection for loose skin, which confers a protective advantage.
== Interactions == Interactions with other drugs acting on the serotonin system or impairing the metabolism of serotonin may increase the risk of serotonin syndrome or neuroleptic malignant syndrome (NMS)-like reaction. Such reactions have been observed with SNRIs and SSRIs alone, but particularly with concurrent use of triptans, MAO inhibitors, antipsychotics, or other dopamine antagonists. The prescribing information states that paroxetine should "not be used in combination with an MAOI (including linezolid, an antibiotic which is a reversible non-selective MAOI), or within 14 days of discontinuing treatment with an MAOI", and should not be used in combination with pimozide, thioridazine, tryptophan, or warfarin. Paroxetine interacts with the following cytochrome P450 enzymes:
{\displaystyle {\begin{aligned}&{\frac {dS}{dt}}=-{\frac {\beta (t)IS}{N}}-v(t)S,\\[6pt]&{\frac {dI}{dt}}={\frac {\beta (t)IS}{N}}-\gamma (t)I,\\[6pt]&{\frac {dR}{dt}}=\gamma (t)I,\\[6pt]&{\frac {dV}{dt}}=v(t)S,\end{aligned}}}
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
tesamorelin 属 GHRH 类似物，作用于垂体受体以促进内源生长激素释放；生长激素本身是直接补充的外源激素。两者在给药逻辑、作用位点和反馈调控路径上并不相同。